@article{Stein2018b,
annote = {Export Date: 23 October 2018},
author = {Stein, D J and Khoo, J P and Ahokas, A and Jarema, M and {Van Ameringen}, M and Vavrusova, L and Hӧschl, C and Bauer, M and Bitter, I and Mosolov, S N and Olivier, V and Matharan, S and Picarel-Blanchot, F and de Bodinat, C},
doi = {10.1016/j.euroneuro.2018.05.006},
journal = {European Neuropsychopharmacology},
number = {8},
pages = {970--979},
title = {12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777{\&}doi=10.1016{\%}2Fj.euroneuro.2018.05.006{\&}partnerID=40{\&}md5=5f86802377e06b860107263afc757430},
volume = {28},
year = {2018}
}

{"_id":"au3agkwKoMBvNcYaY","bibbaseid":"stein-khoo-ahokas-jarema-vanameringen-vavrusova-hschl-bauer-etal-12weekdoubleblindrandomizedmulticenterstudyofefficacyandsafetyofagomelatine2550mgdayversusescitalopram1020mgdayinoutpatientswithseveregeneralizedanxietydisorder-2018","downloads":0,"creationDate":"2019-02-13T11:06:59.795Z","title":"12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder","author_short":["Stein, D J","Khoo, J P","Ahokas, A","Jarema, M","Van Ameringen, M","Vavrusova, L","Hӧschl, C","Bauer, M","Bitter, I","Mosolov, S N","Olivier, V","Matharan, S","Picarel-Blanchot, F","de Bodinat, C"],"year":2018,"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1k6usiZAHS-E_xzhQ-0ainAxbn31RsOz1","bibdata":{"bibtype":"article","type":"article","annote":"Export Date: 23 October 2018","author":[{"propositions":[],"lastnames":["Stein"],"firstnames":["D","J"],"suffixes":[]},{"propositions":[],"lastnames":["Khoo"],"firstnames":["J","P"],"suffixes":[]},{"propositions":[],"lastnames":["Ahokas"],"firstnames":["A"],"suffixes":[]},{"propositions":[],"lastnames":["Jarema"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Van Ameringen"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Vavrusova"],"firstnames":["L"],"suffixes":[]},{"propositions":[],"lastnames":["Hӧschl"],"firstnames":["C"],"suffixes":[]},{"propositions":[],"lastnames":["Bauer"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Bitter"],"firstnames":["I"],"suffixes":[]},{"propositions":[],"lastnames":["Mosolov"],"firstnames":["S","N"],"suffixes":[]},{"propositions":[],"lastnames":["Olivier"],"firstnames":["V"],"suffixes":[]},{"propositions":[],"lastnames":["Matharan"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Picarel-Blanchot"],"firstnames":["F"],"suffixes":[]},{"propositions":["de"],"lastnames":["Bodinat"],"firstnames":["C"],"suffixes":[]}],"doi":"10.1016/j.euroneuro.2018.05.006","journal":"European Neuropsychopharmacology","number":"8","pages":"970–979","title":"12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777&doi=10.1016%2Fj.euroneuro.2018.05.006&partnerID=40&md5=5f86802377e06b860107263afc757430","volume":"28","year":"2018","bibtex":"@article{Stein2018b,\nannote = {Export Date: 23 October 2018},\nauthor = {Stein, D J and Khoo, J P and Ahokas, A and Jarema, M and {Van Ameringen}, M and Vavrusova, L and Hӧschl, C and Bauer, M and Bitter, I and Mosolov, S N and Olivier, V and Matharan, S and Picarel-Blanchot, F and de Bodinat, C},\ndoi = {10.1016/j.euroneuro.2018.05.006},\njournal = {European Neuropsychopharmacology},\nnumber = {8},\npages = {970--979},\ntitle = {12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder},\nurl = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777{\\&}doi=10.1016{\\%}2Fj.euroneuro.2018.05.006{\\&}partnerID=40{\\&}md5=5f86802377e06b860107263afc757430},\nvolume = {28},\nyear = {2018}\n}\n","author_short":["Stein, D J","Khoo, J P","Ahokas, A","Jarema, M","Van Ameringen, M","Vavrusova, L","Hӧschl, C","Bauer, M","Bitter, I","Mosolov, S N","Olivier, V","Matharan, S","Picarel-Blanchot, F","de Bodinat, C"],"key":"Stein2018b","id":"Stein2018b","bibbaseid":"stein-khoo-ahokas-jarema-vanameringen-vavrusova-hschl-bauer-etal-12weekdoubleblindrandomizedmulticenterstudyofefficacyandsafetyofagomelatine2550mgdayversusescitalopram1020mgdayinoutpatientswithseveregeneralizedanxietydisorder-2018","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777&doi=10.1016%2Fj.euroneuro.2018.05.006&partnerID=40&md5=5f86802377e06b860107263afc757430"},"downloads":0},"search_terms":["week","double","blind","randomized","multicenter","study","efficacy","safety","agomelatine","day","versus","escitalopram","day","out","patients","severe","generalized","anxiety","disorder","stein","khoo","ahokas","jarema","van ameringen","vavrusova","hӧschl","bauer","bitter","mosolov","olivier","matharan","picarel-blanchot","de bodinat"],"keywords":[],"authorIDs":[],"dataSources":["mwTox26pHWwQd9xuw"]}